We in turn show that inhibition of GCN2 has anti-myeloma activity in a panel of HMCLs, consistent with previous studies that show GCN2 to be critical for cancer cell survival in solid tumours under conditions of nutrient deprivation44,56. This evidence concerns the gene EIF2AK4 and cancer.